Shoulder Innovations Expanding Next-Generation Shoulder Arthroplasty Portfolio

Published: 23 Sep 2025

Author: Precedence Research

Share :

Shoulder Innovations, Inc., a medical technology company in its commercial stage, is devoted to the development of shoulder surgical care. The company recently announced the commercial launch of the newest innovation, the InSettm 70 Humeral Stem. The new product will be a significant addition to the I-Series of humoral stem products by the company, which started with the introduction of the InSettm 95 in 2024. InSettm 70 is built on the proven characteristics of its predecessor. However, it proposes the benefits of bone-preservation, which can contribute to a more significant range of patient needs.

The InSettm 70 should be used in anatomic arthroplasty, in addition to reverse shoulder arthroplasty. This allows the surgeon to treat a broad range of conditions, such as osteoarthritis, avascular necrosis, rheumatoid arthritis, traumatic arthritis, and functional deformities. It can also be used in cases of irreparable cuff tears, revision surgery, and in cases where adequate bone stock is available in a reverse procedure. The introduction of this new device is another step that Shoulder Innovations takes to become a leader in the shoulder arthroplasty industry. That offering a complete ecosystem of implants, instruments, and facilitating technologies to revolutionize patient care.

The commercial release of the InSettm 70 is not only the release of a product, but it also marks a broader shift in the approach to shoulder care. The orthopedic industry in the world is gradually gravitating toward the use of patient-specific solutions. The increasing range of the company also indicates its long-term investment in the sphere of shoulder arthroplasty. Its purpose is to meet the most urgent demands of the orthopedic community. Furthermore, with the efficiency and the durability provided by the InSettm 70, there is a strong likelihood that it will be instrumental in defining the future of shoulder surgery to focus on value-based care.

Rob Ball, CEO of Shoulder Innovations

“The InSet 70 complements our broad portfolio of advanced shoulder implant solutions, and we are thrilled to bring it to market ahead of schedule. SI has a proud history of innovation, and this launch represents yet another example of technology designed to enhance patient care while delivering real value to surgeons. We believe the InSet 70 will help improve long-term outcomes, preserve bone, and simplify surgical workflows, creating a meaningful impact on the lives of patients across the country.”